Patient - EN
Patient implanted with a single-chamber ICD (Entrust VR) for dilated cardiomyopathy; tachycardia episodes detected in the VT zone; this tracing allows discussing the value of anti-tachycardia pacing in the VT zone.
Graph and trace
The graph shows a tachycardia detected in the VT zone and successfully treated by a burst.
- the EGM shows a regular, monomorphic tachycardia detected in the VT zone;
- an anti-tachycardia pacing sequence (6 stimuli at fixed rate) is delivered;
- termination of the arrhythmia.
NID old - EN
3059
A priority in the programming of an implantable defibrillator is to minimize the delivery of shocks as much as possible without compromising patient safety. Ideally, this entails terminating the tachycardia with the least aggressive and least painful treatment modality possible. Anti-tachycardia pacing is therefore favored as first-line therapy for organized tachycardias comparatively to electrical shocks, being less painful and lowers battery consumption and wear. Moreover, the deleterious effect of electrical shocks has been clearly demonstrated. The principle behind anti-tachycardia pacing is to capture the arrhythmia and interrupt an organized VT by penetrating its propagation circuit through the ventricles. The ventricle must hence be paced at a faster rate than that of the tachycardia. The efficacy of this type of therapy has been demonstrated for a wide range of VT rates up to 240 beats/minute and has consistently been shown to terminate nearly 90% of slow ventricular tachycardias with a rate of less than 200 beats/minute and a moderate risk (1 to 5%) of acceleration. These observations have repositioned the ICD as a first-line treatment of arrhythmias by rapid pacing with the possibility of defibrillation as "back-up" only as needed.
Various parameters must be programmed: